Bluejay Diagnostics, Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
BJDX Nasdaq 3850 bluejaydx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bluejay Diagnostics, Inc.

Bluejay Diagnostics Announces Reverse Stock Split - Nov 13th, 2024 10:10 pm
Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering - Jun 28th, 2024 3:32 pm
Top Midday Decliners - Jun 27th, 2024 6:00 pm
Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering - Jun 27th, 2024 12:58 pm
SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients - Jun 26th, 2024 12:00 pm
BJDX: 1Q:24 Financial Update - May 24th, 2024 9:00 am
BJDX: 2023 Financial Update - Apr 9th, 2024 10:02 am
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering - Jan 2nd, 2024 10:58 pm
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering - Dec 28th, 2023 1:00 pm
BJDX: SYMON Says: Start the Trial! - Dec 28th, 2023 9:57 am
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study) - Dec 27th, 2023 2:00 pm